Published in Indian Heart J on July 27, 2012
Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials. PLoS One (2015) 0.80
Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. Open Heart (2015) 0.76
Effects of different routes of tirofiban injection on the left ventricular function and prognosis of patients with myocardial infarction treated with percutaneous coronary intervention. Exp Ther Med (2015) 0.75
Bivalirudin: the relevance in today's interventional practice. Indian Heart J (2012) 0.75
Universal definition of myocardial infarction. Circulation (2007) 11.69
Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med (2008) 5.86
Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49
Direct thrombin inhibitors. N Engl J Med (2005) 2.15
Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11
Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv (2008) 1.45
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. J Invasive Cardiol (2009) 1.45
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol (2008) 0.95
Effect of bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with heparin alone, heparin + abciximab, or heparin + eptifibatide. Am J Cardiol (2004) 0.81
Antithrombotics and stent type for primary PCI. Lancet (2011) 0.79
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med (2013) 5.02
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.30
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ (2013) 2.26
Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis. JACC Cardiovasc Interv (2010) 2.14
Brugada phenocopy in concomitant ethanol and heroin overdose. Ann Noninvasive Electrocardiol (2014) 2.02
Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation (2006) 1.80
Acute intramural hematoma of the aorta: a mystery in evolution. Circulation (2005) 1.76
Potential impact of the HIPAA privacy rule on data collection in a registry of patients with acute coronary syndrome. Arch Intern Med (2005) 1.68
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2012) 1.65
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 1.63
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol (2006) 1.61
Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol (2012) 1.52
Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature. Catheter Cardiovasc Interv (2010) 1.51
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol (2005) 1.49
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) (2015) 1.49
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 1.45
Eplerenone is not superior to older and less expensive aldosterone antagonists. Am J Med (2012) 1.44
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol (2003) 1.41
Basic cerebral anatomy for the carotid interventionalist: the intracranial and extracranial vessels. Catheter Cardiovasc Interv (2006) 1.41
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2004) 1.34
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease. Arthritis Rheum (2003) 1.13
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2011) 1.13
Liver abnormalities in cardiac diseases and heart failure. Int J Angiol (2011) 1.13
Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg (2004) 1.10
Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem (2004) 1.09
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 1.08
Role of baseline echocardiography in preoperative management of liver transplant candidates. Am J Cardiol (2013) 1.07
Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol (2010) 1.04
Risk Factors in first presentation acute coronary syndromes (ACS): how do we move from population to individualized risk prediction? Angiology (2009) 1.02
Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective. Curr Drug Targets Cardiovasc Haematol Disord (2005) 1.02
Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol (2003) 0.98
Coronary, peripheral and cerebrovascular disease: a complex relationship. J Indian Med Assoc (2010) 0.97
PPAR- γ agonist in treatment of diabetes: cardiovascular safety considerations. Cardiovasc Hematol Agents Med Chem (2012) 0.96
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol (2012) 0.92
Interrelationship between chronic kidney disease and risk of cardiovascular diseases. Cardiovasc Hematol Agents Med Chem (2013) 0.92
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Catheter Cardiovasc Interv (2010) 0.92
Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol (2007) 0.91
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg (2016) 0.89
Atherogenic vascular stiffness and hypertension: cause or effect? JAMA (2012) 0.89
Fibrinolysis for intermediate-risk pulmonary embolism. N Engl J Med (2014) 0.88
Gamma-linolenic acid therapy of human gliomas. Nutrition (2003) 0.88
Carotid artery stenting vs. endarterectomy. Eur Heart J (2009) 0.87
Intensive glucose control in diabetics with an acute myocardial infarction does not improve mortality and increases risk of hypoglycemia-a meta-regression analysis. Curr Vasc Pharmacol (2013) 0.87
Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. Int J Angiol (2007) 0.87
Management of transplant renal artery stenosis. Angiology (2010) 0.86
Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J (2006) 0.86
Current role of emboli protection devices in percutaneous coronary and vascular interventions. Am Heart J (2009) 0.86
Second-generation drug-eluting stents and the continuous need for rapidly available real-world data. JACC Cardiovasc Interv (2009) 0.86
Coronary, peripheral and cerebrovascular disease: a complex relationship. Herz (2008) 0.85
Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein<or=80 mg/dl. Am J Cardiol (2005) 0.85
Developing an action plan for patient radiation safety in adult cardiovascular medicine: proceedings from the Duke University Clinical Research Institute/American College of Cardiology Foundation/American Heart Association Think Tank held on February 28, 2011. J Am Coll Cardiol (2012) 0.85
Effects of cilostazol in patients with Raynaud's syndrome. Am J Cardiol (2003) 0.84
Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases. Curr Vasc Pharmacol (2003) 0.84
Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology (2004) 0.84
PAR-1 antagonists: current state of evidence. J Thromb Thrombolysis (2013) 0.83
Contemporary management of concomitant carotid and coronary artery disease. Heart (2010) 0.83
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. J Thromb Thrombolysis (2013) 0.83
Drug-drug interactions involving antiplatelet agents. Eur Heart J (2003) 0.83
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Kardiol Pol (2015) 0.82
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol (2006) 0.82
Contemporary management of infrapopliteal peripheral arterial disease. Angiology (2011) 0.82
Heparin-induced thrombocytopenia and cardiovascular diseases. Am Heart J (2006) 0.82
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv (2011) 0.81
Clinical problem-solving. Double jeopardy. N Engl J Med (2005) 0.81
A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin. Cardiovasc Hematol Agents Med Chem (2015) 0.81
Carotid brachytherapy for in-stent restenosis. Catheter Cardiovasc Interv (2003) 0.80
Improving quality of care in the real world: efficacy versus effectiveness? Am Heart J (2003) 0.80
MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians. Mol Cell Biochem (2007) 0.80
Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary intervention. Am J Cardiol (2003) 0.80
Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure. Am J Cardiol (2012) 0.79
Optimal medical therapy for coronary artery disease in 2011 - perspectives from the STICH Trial. Cardiovasc Hematol Agents Med Chem (2011) 0.79
Cardiovascular complications of HIV infection and treatment. Cardiovasc Hematol Agents Med Chem (2013) 0.79
Renal artery revascularization: is there a rationale to perform? JACC Cardiovasc Interv (2009) 0.79
Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiol (2013) 0.79
Acute coronary syndromes: unstable angina/non-ST elevation myocardial infarction. Crit Care Clin (2007) 0.79
Response to: Brugada phenocopy: morphological classification and importance of provocative testing. Ann Noninvasive Electrocardiol (2014) 0.78
Emergency intervention for unprotected left main coronary artery stenosis: case report and review of the literature. Hellenic J Cardiol (2011) 0.78
Smoking cessation in patients with acute coronary syndrome. Indian Heart J (2008) 0.78